Tumor necrosis factor, cancer and anticancer therapy

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Tumor necrosis factor (TNF) is explored as an antineoplastic agent for solid tumors.
• Its precise role in cancer therapy remains controversial and incompletely understood.
• Conflicting evidence suggests TNF may also promote cancer progression.

Purpose of the Study:

• To summarize the molecular biology of TNF concerning its tumor-related properties.
• To review experimental and clinical evidence on the complex relationship between TNF, cancer, and therapy.
• To discuss recent insights for exploiting TNF's antineoplastic potential.

Main Methods:

• Literature review of experimental and clinical studies.
• Summary of molecular biology of TNF.
• Discussion of current evidence and recent insights.

Main Results:

• TNF exhibits antineoplastic activity, supporting its use in cancer therapy.
• The molecular mechanisms of TNF-mediated tumor regression require further elucidation.
• Pre-clinical data indicate TNF may also contribute to cancer development and progression.

Conclusions:

• The relationship between TNF, cancer, and antitumor therapy is complex and multifaceted.
• Understanding these complexities is crucial for optimizing TNF-based cancer treatments.
• Further research may unlock new therapeutic strategies involving TNF.